用于磷吸附的载铁（β-FeOOH）沸石制备及特性

以天然沸石为载体,采用FeCl3水解法制备用于磷吸附的载铁沸石（β-FeOOH-Z）,优化β-FeOOH-Z的制备条件,包括FeCl,溶液浓度、负载pH值、负载时间、负载温度和烘干温度,并利用x射线衍射（XRD）和傅里叶变换红外光谱（FTIR）对β-FeOOH-Z及其磷吸附特性进行分析。结果表明,β-FeOOH-Z的优化制备条件为：FeCl3溶液浓度1mol／L、负载pH值6、负载时间24h、负载温度25℃和烘干温度60℃。优化制备条件下,100-120目沸石的载铁量为100．2mg／g,铁的负载率为18％,其磷吸附量为7．68mg／g,比天然沸石提高79．6％。XRD分析结果表明,β-FeOOH-Z中的杂质元素较天然沸石减少,并有效负载β-FeOOH;制备条件对β-FeOOH-Z的成分有较大影响,FeCl,溶液浓度较低、负载温度和烘干温度过高均使β-FeOOH-Z中含有α-Fe2O3,并导致其磷吸附效率降低。FTIR分析结果表明,β-FeOOH-Z的表面羟基在其吸附磷过程中起重要作用,羟基与磷酸根离子的配位交换是β-FeOOH-Z吸附磷的主要作用机制。     

Birth of healthy children after preimplantation diagnosis of β-thalassemia by whole-genome amplification

Preimplantation genetic diagnosis (PGD) offers couples at risk for transmitting an inherited disorder the possibility to avoid the need to terminate affected pregnancies. PGD for monogenic diseases is most commonly accomplished by blastomere biopsy from cleavage-stage embryos, followed by PCR-based DNA analysis. However, the molecular heterogeneity of many monogenic diseases requires a diagnostic strategy capable of detecting a range of mutations and compound genotypes. With the above considerations, we developed an accurate and reliable strategy for analysis of β-globin gene mutations, applicable for PGD for the wide spectrum of β-thalassemia major mutations in the Chinese population. The strategy involves primer-extension preamplification (PEP), followed by nested PCR and reverse dot blot (RDB) for mutation detection since it facilitates simultaneous analysis of more than one mutation in a single cell. This report describes the application of the strategy in two clinical IVF/PGD cycles at risk for transmitting β-thalassemia major, which resulted in the first thalassemia-free children born after PGD in China. Copyright © 2003 John Wiley & Sons, Ltd.     

Kinetic analysis of anaerobic phosphorus release during biological phosphorus removal process

Enhanced biological phosphorus removal (EBPR) is a commonly used and sustainable method for phosphorus removal from wastewater. Poly-β-hydroxybutyrate (PHB), polyphosphate, and glycogen are three kinds of intracellular storage polymers in phosphorus accumulation organisms. The variation of these polymers under different conditions has an apparent influence on anaerobic phosphorus release, which is very important for controlling the performance of EBPR. To obtain the mechanism and kinetic character of anaerobic phosphorus release, a series of batch experiments were performed using the excessively aerated sludge from the aerobic unit of the biological phosphorus removal system in this study. The results showed that the volatile suspended solid (VSS) had an increasing trend, while the mixed liquid suspended sludge (MLSS) and ashes were reduced during the anaerobic phosphorus release process. The interruption of anaerobic HAc-uptake and phosphorus-release occurs when the glycogen in the phosphorus-accumulating-organisms is exhausted. Under the condition of lower initial HAc-COD, HAc became the limiting factor after some time for anaerobic HAc uptake. Under the condition of higher initial HAc-COD, HAc uptake was stopped because of the depletion of glycogen in the microorganisms. The mean ratio of Δρ _P/Δρ _PHB, Δρ _GLY/Δρ _PHB, Δρ _P/ΔCOD, was 0.48, 0.50, 0.44, and 0.92, respectively, which was nearly the same as the theoretical value. The calibrated kinetic parameters of the HAc-uptake and phosphorus-release model were evaluated as follows: Q _HAc,max was 164 mg/(g · h), Q _P,max was 69.9 mg/(g · h), K _gly was 0.005, and KCOD was 3 mg/L. An apparently linear correlation was observed between the ratio of Δρ _P/ΔCOD and pH of the solution, and the equation between them was obtained in this study. Translated from Acta Scientiae Circumstantiae, 2005, 25(9), 1164–1169 [译自: 环境科学学报]     

Analysis of α, β, γ-hexachlorocyclohexanes in water by novel activated carbon fiber-solid phase microextraction coupled with gas chromatography--mass spectrometry

A fast and simple method for determination of α, β,γ-hexachlorocyclohexanes (HCHs) in water using activated carbon fibersolid phase microextraction(ACF-SPME) were studied. Results showed the performance of adsorption and desorption of three HCHs on ACF were excellent. A wide linear range from 10 to 100 μg/L and detection limits of the ng/L level were obtained using ACF-SPME with GC-MS in selected ion monitoring(SIM) acquisition mode. The proposed method was also successfully applied for determination of three HCHs in tap water. Compared to commercial fibers, ACF showed some advantages such as better resistance to solvents, higher thermal stability, longer lifetime and lower cost. The data demonstrated that GC-MS with ACF-SPME is well suitable for the analysis of HCHs in water.     

Variation in the levels of pregnancy- specific β-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies

Human pregnancy-specific β-1-glycoprotein (SP1) was assayed retrospectively in stored maternal serum (MS) samples from 82 chromosomally abnormal pregnancies and 377 matched controls. The median MSSP1 concentration in 48 Down's syndrome pregnancies was significantly elevated at 1.17 multiples of the control median (MOM), and significantly reduced (0.5 MOM) in a group of eight cases of unbalanced translocations. There was no significant difference in median SP1 concentrations in cases of trisomy 18, trisomy 13, balanced translocations, or sex chromosome abnormalities. A comparison with human chorionic gonadotrophin results in the same series of samples indicates that SP1 is a less sensitive predictor of Down's syndrome pregnancies.     

β-Glucuronidase activity in mouse oocytes,mouse preimplantation embryos,and human gametes

A microfluorimetric assay was designed to monitor β-glucuronidase (β-gluc) activity during the early development of mouse embryos and was also applied to measure β-gluc activity in human sperm cells and single human oocytes. Mouse oocytes and preimplantation embryos at different stages of development, failed fertilized human oocytes, and human sperm cells were collected, and β-gluc activity was analysed. In the mouse, β-gluc activity could be measured starting from the morula stage on in a pooled sample of 15 embryos and at blasto-cyst formation in one single embryo. β-Gluc activity was low in human sperm cells. The enzyme could be readily demonstrated in 87 per cent of non-fertilized human oocytes. Considerable variation in β-gluc activity was noticed between individual oocytes.     

Problems in prenatal diagnosis of β-thalassaemia by fetal blood analysis: β-chain variant comigrating with gamma chains

This report describes a couple at risk for β thalassaemia in which one spouse was heterozygous for classical high Hb A2 β-thalassaemia while the other had the compound heterozygous state for β⁺-thalassaemia and a β-chain variant. This variant comigrates on carboxymethyl-cellulose columns (CMC) with γ-chains, indicating that globin separation on CMC columns could not have been used for fetal diagnosis. The β-chain variant migrates separately from the other globin chains on HPLC and the respective abnormal haemoglobin can be separated by isoelectrofocusing. Oligonucleotide hybridization showed that both parents were carriers of the β⁺ IVS-1, nt 6 mutation. Prenatal diagnosis was successfully accomplished by oligo-nucleotide analysis on trophoblast DNA. This case indicates that an Antenatal Service should have alternative methods to CMC columns so as to carry out prenatal diagnosis of β-thalassaemia in uncommon cases.     

Prenatal diagnosis of a heterozygote for mucopolysaccharidosis type VII (β-glucuronidase deficiency)

We had the opportunity of investigating a case (BK) of a severe form of mucopolysacchari- dosis with nearly total deficiency of β-glucuronidase in serum, leucocytes and fibroblasts. We here report results obtained by prenatal diagnosis of a clinically normal child (BK's sister), and point out the difficulty in interpreting a heterozygous level of β-glucuronidase activity in cultured amniotic cells. Four successive passages of amniotic cells were tested for β-glucuronidase and α-mannosidase activity in at-risk and control cells. In different passages, enzyme activity was between 8 and 49 per cent of controls but 2 to 18 times higher than fibroblasts from the affected brother (BK). The highest activity was observed in the first passage and the lowest in the third. The electrophoretic separation of GAGS from at-risk amniotic fluid showed a normal pattern. We discuss the correlation between enzyme levels in different passages of cultured cells and that found in leucocytes and fibroblasts from the propositus and parents. From a practical point of view, we conclude that the first passage gives the most reliable results for prenatal diagnosis.     

First trimester diagnosis of β-thalassaemia in a twin pregnancy

This paper reports the results of first trimester prenatal diagnosis in a twin pregnancy at risk for homozygous β°−thalassaemia (β°−39 mutant). Trophoblast samples from both twins were obtained at 10 weeks gestation with a forceps guided by ultrasound. Trophoblast DNA analysis, carried out with the oligonucleotide technique, revealed that one fetus was homozygous and the other heterozygous for the β−39 mutant. This diagnosis was confirmed at 17 weeks gestation by amniocyte DNA analysis. DNA polymorphism analysis within the α-globin gene provided useful genetic markers for twin differentiation.